基础医学与临床 ›› 2021, Vol. 41 ›› Issue (9): 1266-1271.

• 研究论文 • 上一篇    下一篇

双氢青蒿素减轻失血性休克大鼠肺损伤

杨宁*, 王大伟, 赵雅彬, 常东歌, 何莹莹   

  1. 郑州大学附属郑州中心医院 急诊与重症医学部,河南 郑州 450007
  • 收稿日期:2020-07-09 修回日期:2021-02-18 出版日期:2021-09-05 发布日期:2021-09-02
  • 通讯作者: *13623840795@163.com
  • 基金资助:
    河南省科技攻关计划(182102310177)

Dihydroartemisinin reduces lung injury in rats with hemorrhagic shock

YANG Ning*, WANG Da-wei, ZHAO Ya-bin, CHANG Dong-ge, HE Ying-ying   

  1. Department of Emergency and Critical Care Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China
  • Received:2020-07-09 Revised:2021-02-18 Online:2021-09-05 Published:2021-09-02
  • Contact: *13623840795@163.com

摘要: 目的 研究双氢青蒿素(DHA)对失血性休克(HS)大鼠肺损伤的保护作用。方法 将大鼠分为假手术组、模型组(左侧颈总动脉放血,放血量约为血容量35%,平均动脉压降至35~45 mmHg,以2倍放血量的林格氏液复苏)及DHA低、高剂量组(每天6、12 mg/kg DHA灌胃)、地塞米松组(每天10 mg/kg地塞米松灌胃)。连续干预7 d。测定肺湿重/干重(W/D)值,酶联免疫吸附测定(ELISA)肺组织髓过氧化物酶(MPO)活性、白介素-12(IL-12)、白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)水平;羟胺法测定超氧化物歧化酶(SOD)活性,硫代巴比妥酸比色法测定丙二醛(MDA)水平;HE染色观察肺组织病理;Western blot检测肺组织Toll样受体4(TLR4)、髓样分化因子88(MyD88)、核转录因子κB(NF-κB)p65、p-NF-κB p65蛋白相对表达量。结果 与假手术组比较,模型组肺W/D,肺组织MDA、IL-12、IL-1β、TNF-α水平,MPO活性,TLR4、MyD88蛋白相对表达量,p-NF-κB p65/NF-κB p65均显著升高,而SOD活性显著减弱(P<0.05);与模型组比较,DHA低、高剂量组以及地塞米松组肺W/D,肺组织MDA、IL-12、IL-1β、TNF-α水平,MPO活性,TLR4、MyD88蛋白相对表达量,p-NF-κB p65/NF-κB p65均显著降低,而SOD活性显著增强(P<0.05)。模型组肺部大量炎性细胞浸润,肺间质水肿明显,肺泡数量明显减少;DHA低、高剂量组,地塞米松组干预后,上述病理变化向正常好转。结论 DHA可减轻HS后肺部病理改变、肺水肿、氧化损伤及炎性反应,抑制TLR4、MyD88表达及NF-κB磷酸化,具有肺损伤的保护作用。

关键词: 失血性休克, 双氢青蒿素, Toll样受体4, 髓样分化因子88

Abstract: Objective To study the protective effect of dihydroartemisinin (DHA) on lung injury in rats with hemorrhagic shock (HS). Methods The rats were divided into sham operation group, model group (the left common carotid artery was treated by blood-letting, the blood volume was about 35% of the blood volume, the average arterial pressure dropped to 35~45 mmHg, and the Ringer's solution was resuscitated with twice the blood volume), DHA low- and high-dose groups (6 and 12 mg/kg DHA per day), dexamethasone group (10 mg/kg dexamethasone per day). Intervene was carried out continuously for 7 days. The wet weight/dry weight ratio(W/D) of the lung was measured.ELISA was used to determine the activity of myeloperoxidase (MPO), the level of IL-12, IL-1β and TNF-α in lung tissue. Hydroxylamine method was used to determine the activity of superoxide dismutase (SOD). The thiobarbituric acid colorimetric method was used to determine the malondialdehyde (MDA) level. HE staining was used to observe lung tissue pathology. Western blot was used to detect the relative expression of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), nuclear transcription factor κB (NF-κB) p65, and p-NF-κB p65 protein in lung tissue. Results Compared with the sham operation group, the lung W/D, MDA, IL-12, IL-1β, and TNF-α levels, MPO activity, relative expression of TLR4, MyD88 protein, p-NF-κB p65/NF -κB p65 were all significantly increased in the model group, but SOD activity was significantly decreased(P<0.05). Compared with the model group, lung W/D, lung tissue MDA, IL-12, IL-1β, and TNF-α levels, MPO activity, relative expression of TLR4, MyD88 protein, p-NF-κB p65/NF -κB p65 were significantly reduced in the low-dose and high-dose groups of DHA and the dexamethasone group, of which the SOD activity was significantly enhanced (P<0.05). The model group was infiltrated with a large number of inflammatory cells, the pulmonary interstitial edema was obvious, and the number of alveoli was significantly reduced. The above-mentioned pathological changes improved after intervention in DHA low- and high-dose groups and dexamethasone group. Conclusions DHA reduces pathological changes, edema, oxidative damage and inflammation of lung tissue after HS, inhibits the expression of TLR4, MyD88 and NF-κB phosphorylation, and shows a protective effect on lung injury.

Key words: hemorrhagic shock, dihydroartemisinin, Toll-like receptor 4, myeloid differentiation factor 88

中图分类号: